The Binary-Gate Problem in Cleared Devices

Cleared autonomous medical devices overwhelmingly govern action with binary permit-suppress logic: a controller evaluates the current patient state, decides whether the contemplated action is within bounds, and either commits it or holds. The logic is deterministic, easy to verify, and well matched to narrow-indication devices whose action space is small. Closed-loop insulin platforms, ventilator weaning controllers, and autonomous infusion systems all operate inside tight indication-specific bounds for exactly this reason: their binary gate does not generalize, so the cleared safety case keeps the action space narrow.

The weakness surfaces when the device's confidence in its own readiness degrades during a procedure. A surgical step-progression controller encountering unexpected anatomy, a ventilator facing a patient state outside its characterized envelope, or an infusion controller whose sensor lineage has become unreliable all reach a point where continuing to act is unsafe but a hard-stop is also unsafe, because an abruptly abandoned partial action can be worse than either completing it or never starting. Binary logic has no disciplined state for this. It cannot stop acting while continuing to reason, forecast a recovery path, and formulate a question for the clinician, because in a binary architecture "not executing" and "not thinking" are the same state.

Confidence Governance as the Actuation Primitive

Confidence Governance, as disclosed in Chapter 5 of United States Patent Application 19/647,395, supplies exactly the missing structure. Its core move is to make confidence a first-class computed state variable rather than an implicit property of the controller. Confidence is computed by a composite evaluator over agent-state and task-state inputs, it carries both a value and a rate of change, and it is recorded in the device's lineage so that every authorization decision is reconstructable after the fact.

That computed confidence gates execution as a revocable permission. Authorization is not a flag the actuator checks and optionally respects; the disclosed mechanism implements a structural decoupling of the execution subsystem's output pathway, so that when authorization is withdrawn the actuator cannot produce externally observable effects regardless of its internal state or the urgency of its intent. For a medical actuator this is the property that matters most: the gate is a hard constraint enforced below the level at which the controller's own self-assessment or any affect-like pressure could override it.

The disclosed gate operates in three authorization states, which map cleanly onto the operating modes a regulated device needs:

  • Authorized. Confidence is above the authorization threshold and its trajectory triggers no alarm; the actuator may commit actions. This is the normal operating mode.
  • Suspended. Confidence has fallen below the threshold, or a trajectory-based alarm has triggered pre-emptive suspension; execution is prohibited but the device's cognitive processes continue. For a medical device this is the disciplined intermediate state binary logic lacks: the device stops actuating while it keeps forecasting, planning, and inquiring.
  • Locked. A severe integrity violation, a catastrophic resource failure, or a governance-mandated halt has occurred; both execution and certain cognitive processes are restricted pending external review. The transition into locked is governance-mandated and is not reversible by the device itself; recovery requires external authorization.

Pre-emptive Suspension and the Non-Executing Mode

Two further mechanisms from the same disclosure make the primitive fit the clinical setting.

First, the governor does not wait for confidence to cross the threshold before reacting. Because confidence carries a rate of change, a trajectory-based alarm can trigger pre-emptive suspension while the value is still above the threshold but trending toward it. In a medical context this is the difference between a device that halts after it has already begun an unsafe commitment and one that suspends before the commitment, having projected that its readiness is decaying.

Second, when the device suspends, the disclosed non-executing cognitive mode preserves its reasoning capacity while removing its ability to act. In this mode the device continues constructing planning graphs with modified parameters (broader search, longer temporal horizon), generates inquiries directed at the clinician or external sources, and performs self-assessment, all without producing actuation. The forecasting engine feeds this loop: when it determines that no viable path forward exists, it transmits a negative-viability signal that reduces confidence and holds the device in the non-executing mode, ensuring the device pauses rather than acts when it has no plan it can justify. For autonomous medical execution this realizes a fail-operational rather than fail-silent posture: a suspended device is still working the problem and still asking for help, it simply cannot move the patient state until authorization returns.

Recovery Under Hysteresis

A device that flips authorization on and off as confidence fluctuates near the threshold would be clinically unacceptable. The disclosed recovery rule prevents this directly: the transition from suspended back to authorized requires that confidence exceed the authorization threshold by a configurable hysteresis margin, so the device does not oscillate between acting and not-acting when its confidence hovers at the boundary. Recovery of authorization can additionally be staged through a restoration, stability-verification, and reauthorization sequence before execution resumes. For a regulated device this hysteresis is the property that turns "the controller's confidence went up briefly" into a deliberate, reconstructable decision to resume, recorded in lineage like every other authorization event.

Deployment Embodiments

The primitive is a layer above the device-specific control law, so it applies across the autonomous-medical landscape rather than to a single instance. Concrete embodiments include:

  • Surgical step progression. Each contemplated step is gated by computed confidence over the device's perception of anatomy and tissue response. Encountering unexpected anatomy drives a trajectory-based pre-emptive suspension before the step is committed; the device enters the non-executing mode, forecasts alternative approaches, and surfaces an inquiry to the surgeon rather than proceeding on degraded readiness.
  • Mechanical ventilation under varying patient state. Confidence is computed over task-state inputs describing how well the current patient state matches the device's characterized envelope. Drift toward an uncharacterized state suspends autonomous adjustment, holding ventilation at the last authorized setting while the device reasons and signals, with hysteresis governing return to autonomous control.
  • Closed-loop insulin and infusion. The binary permit-suppress admissibility logic these devices already use is retained as the initial threshold test, but wrapped so that execution becomes a revocable permission with recorded confidence trajectory. Sensor-lineage degradation drives suspension; recovery requires the hysteresis margin, preventing dose oscillation near the boundary.
  • Clinical-decision-support actuators. Confidence gating distinguishes the authorized regime, in which the actuator may commit, from the suspended regime, in which it downgrades to advisory output and inquiry while continuing to forecast.

A pragmatic adoption sequence wraps a single cleared narrow-indication device in the confidence governor with binary permit-suppress retained as the initial admissibility logic, so the device immediately produces recorded confidence and authorization lineage that exceeds what a procedural model alone produces. As post-market evidence accumulates, trajectory-based pre-emptive suspension and the non-executing cognitive mode are activated within the device's change-control envelope, widening the indication footprint without re-architecting the safety case.

Alignment with the Regulatory Direction of Travel

The mechanism aligns structurally with where medical-device regulation is heading, without depending on any single framework. Software-as-a-Medical-Device guidance, predetermined change-control plans, quality-system regulation, software-lifecycle standards, and the European medical-device and AI regimes are converging on the same demands: that the boundaries of authorized behavior be made explicit, that deviations from expected behavior be detectable, and that the resulting evidence be auditable across the device's post-market lifecycle. Confidence-gated execution answers each of these structurally rather than procedurally. The authorization threshold makes the boundary of authorized behavior explicit. The trajectory-based alarm makes degradation toward that boundary detectable before a failure. The lineage record of confidence values, authorization transitions, and the reasoning the device performed while suspended makes the evidence auditable. A purely procedural response layers more documentation onto a binary architecture; confidence governance changes the architecture so that the documented properties are produced by the device's own operation.

Disclosure Scope

This article describes an application of Confidence Governance as disclosed in United States Patent Application 19/647,395. The medical domain framing, regulatory context, market analysis, and deployment scenarios are presented as enabling implementations of the disclosed mechanism and are external to the claimed invention. The technical mechanisms relied upon, confidence as a first-class computed state variable, execution as a revocable permission, the hard three-state authorization gate (authorized, suspended, locked), trajectory-based pre-emptive suspension, the non-executing cognitive mode of forecasting, planning, and inquiry, and hysteresis on recovery, are disclosed in that application. No thresholds, latencies, benchmarks, or numerical values beyond those in the cited application are asserted.